Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

• Paul J. Hampel,
• Sameer A. Parikh,
• Timothy G. Call,
• Mithun V. Shah,
• N. Nora Bennani,
• Aref Al-Kali,
• Kari G. Rabe,
• Yucai Wang,
• Eli Muchtar,
• Jose F. Leis,
• Saad S. Kenderian,
• Amber B. Koehler,
• Susan M. Schwager,
• Susan L. Slager,
• Neil E. Kay,
• Curtis A. Hanson,
• Daniel L. Van Dyke,
• Min Shi,
• Wei Ding

Affiliations

Paul J. Hampel

Division of Hematology, Department of Medicine, Mayo Clinic

Sameer A. Parikh

Division of Hematology, Department of Medicine, Mayo Clinic

Timothy G. Call

Division of Hematology, Department of Medicine, Mayo Clinic

Mithun V. Shah

Division of Hematology, Department of Medicine, Mayo Clinic

N. Nora Bennani

Division of Hematology, Department of Medicine, Mayo Clinic

Aref Al-Kali

Division of Hematology, Department of Medicine, Mayo Clinic

Kari G. Rabe

Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic

Yucai Wang

Division of Hematology, Department of Medicine, Mayo Clinic

Eli Muchtar

Division of Hematology, Department of Medicine, Mayo Clinic

Jose F. Leis

Department of Hematology and Oncology, Mayo Clinic

Saad S. Kenderian

Division of Hematology, Department of Medicine, Mayo Clinic

Amber B. Koehler

Division of Hematology, Department of Medicine, Mayo Clinic

Susan M. Schwager

Division of Hematology, Department of Medicine, Mayo Clinic

Susan L. Slager

Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic

Neil E. Kay

Division of Hematology, Department of Medicine, Mayo Clinic

Curtis A. Hanson

Department of Laboratory Medicine and Pathology, Mayo Clinic

Daniel L. Van Dyke

Department of Laboratory Medicine and Pathology, Mayo Clinic

Min Shi

Department of Laboratory Medicine and Pathology, Mayo Clinic

Wei Ding

Division of Hematology, Department of Medicine, Mayo Clinic